GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » Price-to-Owner-Earnings

Morepen Laboratories (NSE:MOREPENLAB) Price-to-Owner-Earnings : 52.80 (As of Jun. 09, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories Price-to-Owner-Earnings?

As of today (2024-06-09), Morepen Laboratories's share price is ₹48.05. Morepen Laboratories's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹0.91. It's Price-to-Owner-Earnings for today is 52.80.


The historical rank and industry rank for Morepen Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

NSE:MOREPENLAB' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 25.95   Med: 54.63   Max: 183.64
Current: 52.82

During the past 13 years, the highest Price-to-Owner-Earnings of Morepen Laboratories was 183.64. The lowest was 25.95. And the median was 54.63.


NSE:MOREPENLAB's Price-to-Owner-Earnings is ranked worse than
79.43% of 423 companies
in the Drug Manufacturers industry
Industry Median: 25.31 vs NSE:MOREPENLAB: 52.82

As of today (2024-06-09), Morepen Laboratories's share price is ₹48.05. Morepen Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.89. Therefore, Morepen Laboratories's PE Ratio for today is 25.42.

As of today (2024-06-09), Morepen Laboratories's share price is ₹48.05. Morepen Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was ₹1.89. Therefore, Morepen Laboratories's PE Ratio without NRI for today is 25.42.

During the past 13 years, Morepen Laboratories's highest PE Ratio without NRI was 58.51. The lowest was 12.34. And the median was 26.96.


Morepen Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for Morepen Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories Price-to-Owner-Earnings Chart

Morepen Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 37.33 - - 46.21

Morepen Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 46.21

Competitive Comparison of Morepen Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's Price-to-Owner-Earnings falls into.



Morepen Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Morepen Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=48.05/0.91
=52.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morepen Laboratories  (NSE:MOREPENLAB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Morepen Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories (NSE:MOREPENLAB) Business Description

Traded in Other Exchanges
Address
2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines